EICHOR
● Active Not Recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
Condition: Prurigo Nodularis · Sponsor: Incyte Corporation
About this study
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (120)
| Cahaba Dermatology | Birmingham, Alabama, United States | — |
| Banner - University Medicine Multispecialty Services Clinic | Tucson, Arizona, United States | — |
| Premier Dermatology Clinical Trials Institute At Northwest Arkansas | Fayetteville, Arkansas, United States | — |
| Burke Pharmaceutical Research | Hot Springs, Arkansas, United States | — |
| Dermatology Research Associates | Los Angeles, California, United States | — |
| Northridge | Northridge, California, United States | — |
| Rendon Center the Dermatology and Aesthetic Center | Boca Raton, Florida, United States | — |
| Driven Research Llc | Coral Gables, Florida, United States | — |
| University of Miami Miller School of Medicine | Miami, Florida, United States | — |
| Research Institute of the Southeast, Llc | West Palm Beach, Florida, United States | — |
| Illinois Dermatology Institute the Chicago Loop | Chicago, Illinois, United States | — |
| Chicago Cosmetic Surgery and Dermatology | Chicago, Illinois, United States | — |
+ 108 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06516952